Answers are grounded in this paper and cite their sources.
Sorbaria tomentosa (Lindl.), is a graceful shrub bearing a science-based health benefits. This study aimed at assessing the anticancer potential of ethyl-acetate fractions (EtOAc) of S. tomentosa, and to identify bioactive natural compounds using HPLC and LC-MS techniques. Prior to the chromatographic analysis, four sub-fractions (SPE-1-SPE-4) were obtained from solid phase extraction (SPE) of EtOAc of the methanolic plant extract. SPE-2 fraction exhibited considerable levels of cytotoxicity (IC50: 50-75 µg/mL) than the rest of the sub-fractions with IC50 ranging in between 230-370 µg/mL against A-549, HepG2, and EI-138 human the cancer cell lines. SPE-2 was injected into a semi-preparative reverse HPLC-based-PDA revealing the occurrence of phenolic compounds. LC-MS analysis resulted in the identification of four bioactive phenolic compounds namely trans-p-sinapoyl-β-D-glucopyranoside (1), dunnianoside F (2), linoside A (3), and asplenetin (4) in SPE-2. In conclusion, the isolated compounds from the SPE-2 sub-fraction are the potential source of marked phenolic compounds that might be a promising option as anticancer agents in both cancer prevention and treatment.
No takes yet. Share an insight, caveat, or question.
Javed et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: